Submit your claim details for a free, no obligation case review
Get Started:
A man from Virginia filed a personal injury lawsuit against Amylin Pharmaceuticals, the manufacturer, and Eli Lilly and Co., the co-marketer of the diabetes drug Byetta (R). The lawsuit, filed in the San Diego Superior Court, alleges that the two defendant companies failed to properly inform patients of the drug’s harmful affects.
According to the lawsuit, the plaintiff had to be hospitalized in December 2007 for inflammation of his pancreas, a condition otherwise known as pancreatitis, as a result of taking Byetta (R) for diabetes. Pancreatitis causes internal bleeding and can result in death.
In 2007, after negotiating with the FDA, Amylin Pharmaceuticals added the risk of developing acute pancreatitis to the list of “precautions” on the drug’s warning label. The “warning” was reportedly a direct result of 30 cases of acute pancreatitis among diabetics who took Byetta (R).
Although the condition is listed on the warning label, the plaintiff claims the warning was simply not enough. The lawsuit states that the defendant, “ failed to adequately warn prescribing physicians of the risk of pancreatitis, of measures needed to properly assess the appropriateness of prescribing the drug to certain categories of patients, and of measures doctors and patients could and should take to minimize the risk."
The FDA reported, two days after the lawsuit was filed, an additional six cases of pancreatitis. All of the patients had been prescribed the drug to treat diabetes. Two of the six patients died while the other four suffered serious injuries and pain.
Amylin reported that two more people died from inflamed pancreas’ September 7.
(Source: InjurBoard.com)
Have you or someone you know been harmed by Byetta (R) or a drug that has been recalled? If so, contact us today to speak to an experienced personal injury attorney who will carefully evaluate your case and fight to protect your rights.